The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.

The new weight-loss tablet was developed in a lab and is based on “a type of β2 agonist.” As explained in the news release: ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...

Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition experts say, don't forget the simple foods that were out there controlling appetites first.

Newly discovered molecule rivals Ozempic in weight loss – with fewer side effects. Stanford researchers have identified a naturally occurring molecule that can suppress appetite and facilitate ...

You may have heard about Ozempic, a medicine for type 2 diabetes approved by the FDA in 2017. This medicine is for use with diet and exercise to improve control of blood glucose levels in people ...

Anaturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide — also known as Ozempic — in suppressing appetite and reducing body weight. Notably, testing in ...